Hematologic System Flashcards
Medication Administration IV Iron (ferrous sulfate)
Give test dose of 25 mg to determine sensitivity. Have epinephrine available in case of hypersensitivity. Follow with prescribed dose one hour later
Medication Administration Oral iron (ferrous sulfate)
Liquid: dilute with compatible liquid and give with a straw
Spread oral doses evenly over waking hours to maximize productions of RBCs
Give on an empty stomach for best absorption
Client Education ferrous sulfate (Anti-anemic)
Take on an empty stomach. If GI effects are too much, take with food
Stool may become dark green or black - harmless
Increase exercise and fiber intake if constipation occurs
Suck on hard candy or chew gum to relieve metallic taste
Interactions ferrous sulfate (anti-enemic)
Antacids reduce absorption
Vitamin C increases absorption, but also increases GI effects
Absorption of tetracyclines, fluoroquinolones, bisphosphates and penicillamine, will decrease administered with iron supplements
Concurrent use with ACE inhibitors may increase the risk of anaphylactic reaction with iron dextran
Evaluation of Medication Effectiveness ferrous sulfate (anti-anemic)
Increased reticulocyte count is expected within 4 to 7 days after beginning iron therapy
Increase in hemoglobin of 2 g/dL is expected 1 month after beginning therapy
Fatigue and pallor (skin, mucous membranes) should subside, and the client reports increased energy level
Adverse Effects
Vitamin B12
Erythema
Hypertension
Hypokalemia
Interactions
Vitamin B12
Folic acid can mask the symptoms of B12 deficiency; clients must take adequate doses of cyanocobalamin
Chloramphenicol (Chlormycetin) decreases effectiveness
Alcohol, cimetidine (Tagament), colchicine (Colcrys), and aminosalicyclic acid (Paser) reduce the absorption of oral form
Ascorbic acid (vitamin C) alters the stability of oral forms
Therapeutic Use
Vitamin B9 folate
Megaloblastic (macrocytic) anemia Folate deficiency (alcoholism) Prevent neural tube defects in developing fetus
Adverse Effects
Vitamin B9 folate
Increased yellowing of urine
Masks B12 deficiency in high doses
Increased risk of developing colorectal or prostate cancer (long-term use)
Therapeutic Use
factor VIII and factor IX
Hemophilia A (factor VIII) Hemophilia B (factor IX)
Adverse Effects
factor VIII and factor IX
Allergic reaction
Creutzfeldt-Jakob disease (minimal risk, plasma-derived products only)
Adverse Effects Antidiuretic hormone (desmopressin)
Fluid retention, hyponatremia
Seizures, drowsiness, headache, nausea, and mild GI discomfort
Therapeutic Use
heparin, enoxaparin
Anticoagulation for evolving cerebrovascular accident, pulmonary embolism, massive deep-venous thrombosis
Adjunct therapy during angioplasty, open-heart surgery, hemodialysis, blood transfusion
Prophylaxis for postoperative venous thrombosis and pulmonary emboli
Acute myocardial infarction (with thrombolytic therapy)
Ischemic complications of unstable angina and some dysrhythmias
Disseminated intravascular coagulation
Adverse Effects
heparin, enoxaparin
Bleeding/hemorrhage
Thrombocytopenia (low platelet count)
Hypersensitivity reactions
Neurological injury (from hematoma formation during lumbar puncture, epidural anesthesia)
Nursing Interventions
heparin, enoxaparin
For heparin overdose, stop heparin and administer protamine, which binds to heparin to form a heparin-protamine complex that has no anticoagulant properties
Administer IV protamine no faster than 20mg/min or 50 mg in 10 minutes
Monitor vital signs, checking for hypotension and tachycardia
Monitor activated partial thromboembolism time (aPTT), making sure it is no higher than twice the baseline value
Monitor platelet count periodically throughout treatment, especially in the first month
Stop heparin for for platelet counts below 100,000/mm3 and administer a non-heparin anticoagulant, such as lepirudin
Administer a small test dose first
Monitor for itching and rash or hives
Monitor for spinal insertion site for signs of hematoma formation, such as bruising or swelling
Monitor sensation and movement of lower extremities